References and Notes
-
1a
Bradshaw JWS.
Baker R.
Howse PE.
Nature (London)
1975,
258:
230
-
1b
Garson MJ.
Chem. Rev.
1993,
93:
1699
-
1c
D’Auria MV.
Minale L.
Riccio R.
Chem. Rev.
1993,
93:
1839
-
1d
Senokuchi K.
Nakai H.
Nakayama Y.
Odagaki Y.
Sakaki K.
Kato M.
Maruyama T.
Miyazaki T.
Ito H.
Kamiyasu K.
Kim S.
Kawamura M.
Hamanaka N.
J. Med. Chem.
1995,
38:
4508
-
1e
Senokuchi K.
Nakai H.
Nakayama Y.
Odagaki Y.
Sakaki K.
Kato M.
Maruyama T.
Miyazaki T.
Ito H.
Kamiyasu K.
Kim S.
Kawamura M.
Hamanaka N.
J. Med. Chem.
1995,
38:
2521
-
1f
Watanabe T.
Hayashi K.
Yoshimatsu S.
Sakai K.
Takeyama S.
Takashima K.
J. Med. Chem.
1980,
23:
50
- 2
Marfat A.
McGuirk PR.
Helquist P.
J. Org. Chem.
1979,
44:
3888
-
3a
Kelly SE.
Additions to C-X π-Bonds In Comprehensive Organic Synthesis
Part 1:
Schreiber SL.
Pergamon Press;
Oxford:
1991.
-
3b
Masaki Y.
Sakuma K.
Kaji K.
J. Chem. Soc., Chem. Commun.
1980,
434
-
3c
Brown HC.
Basavaiah D.
J. Org. Chem.
1982,
47:
5407
-
3d
Denmark SE.
Amburgey J.
J. Am. Chem. Soc.
1993,
115:
10386
-
3e
Amri H.
Rambaud M.
Villieras J.
Tetrahedron
1990,
46:
3535
-
3f
Katzenellenbogen JA.
Utawanit T.
J. Am. Chem. Soc.
1974,
96:
6153
-
3g
Kocienski PJ.
Ansell JM.
Ostrow RW.
J. Org. Chem.
1976,
41:
3625
-
3h
Miller JA.
Zweifel G.
J. Am. Chem. Soc.
1981,
103:
6217
-
3i
Coutrot P.
Ghribi A.
Synthesis
1986,
790
-
3j
Rossi R.
Carpita A.
Cossi P.
Tetrahedron
1992,
48:
8801
-
3k
Basavaiah D.
Krishnamacharyulu N.
Hyma RS.
Sarma PKS.
Kumaragurabaran M.
J. Org. Chem.
1999,
64:
1197
-
4a Baylis AB, and Hillman MED. inventors; DE 2155113.
; Chem. Abstr. 1972, 77, 34174q
-
4b
Ciganek E.
Org. React.
1997,
51:
201
-
4c
Basavaiah D.
Rao PD.
Hyma RS.
Tetrahedron
1996,
52:
8001
-
4d
Basavaiah D.
Rao AJ.
Satyanarayana T.
Chem. Rev.
2003,
103:
811
-
5a
Basavaiah D.
Dharma Rao P.
Suguna HR.
Tetrahedron
1996,
52:
8001
-
5b
Yadav JS.
Gupta MK.
Pandey SK.
Reddy BVS.
Sarma AVS.
Tetrahedron Lett.
2005,
46:
2761
-
5c
Fuocaud A.
EI Guemmont F.
Bull. Soc. Chim. Fr.
1989,
403
-
5d
Ko SH.
Lee K.-J.
J. Heterocycl. Chem.
2004,
41:
613
-
6a
Basavaiah D.
Suguna HR.
Muthukumara K.
Kumaragurubaran N.
Synthesis
2000,
217
-
6b
Roy O.
Riahi A.
Henin F.
Muzart J.
Tetrahedron
2000,
56:
8133
- 7
Kamaimura A.
Morita R.
Matsuura K.
Mitsudera H.
Shirai M.
Tetrahedron
2003,
59:
9931
- 8
Kabalka GW.
Venkataiah B.
Dong G.
Tetrahedron Lett.
2003,
44:
4673
- 9
Basabaiah D.
Satyanarayana T.
Tetrahedron Lett.
2002,
43:
4301
-
10a
Kim JN.
Chung YM.
Im Y.
Tetrahedron Lett.
2002,
43:
6209
-
10b
Chung YM.
Lee HJ.
Hwang SS.
Kim JN.
Bull. Korean Chem. Soc.
2001,
22:
799
- 11
Basavaiah D.
Bhavani AKD.
Pandiaraju S.
Sarma PKS.
Synlett
1995,
243
-
12a
Basavaiah D.
Sarma PKS.
J. Chem. Soc., Chem. Commun.
1992,
955
-
12b
Rabe J.
Hoffmann HMR.
Angew. Chem., Int. Ed. Engl.
1985,
50:
3849
-
12c
Im YJ.
Kim JM.
Mun JH.
Kim JN.
Bull. Korean Chem. Soc.
2001,
22:
349
- 13
Lee CH.
Song YS.
Cho HI.
Yang JW.
Lee K.-J.
J. Heterocycl. Chem.
2003,
40:
1103
- 14
Chandrasekhar S.
Saritha B.
Jagadeshwar V.
Narsihmulu C.
Vijay D.
Sarma GD.
Jagadeesh B.
Tetrahedron Lett.
2006,
47:
2981
- 15
Srihari P.
Sigh AP.
Jain R.
Yadav JS.
Synthesis
2006,
2772
- 16
Liu YK.
Xu XS.
Zheng H.
Xu DQ.
Xu ZY.
Zhang YM.
Synlett
2006,
571
- 17
Hong WP.
Lee K.-J.
Synthesis
2005,
33
-
18a
Basavavaiah D.
Sarma PKS.
Bhavani AKD.
J. Chem. Soc., Chem. Commun.
1994,
1091
-
18b
Amri H.
Rambaud M.
Villieras J.
J. Organomet. Chem.
1990,
384:
1
-
18c
Amri H.
Rambaud M.
Villieras JJ.
Tetrahedron
1990,
46:
3535
-
18d
Song YS.
Lee K.-J.
J. Heterocycl. Chem.
2006,
43:
1721
- 19
Das B.
Banerjee J.
Mahender G.
Majhi A.
Org. Lett.
2004,
6:
3349
-
20a
Liu YK.
Li J.
Zheng H.
Xu DQ.
Xu ZY.
Zhang YM.
Synlett
2005,
2999
-
20b
Liu YK.
Zheng H.
Xu DQ.
Xu ZY.
Zhang YM.
Synlett
2006,
2492
-
20c
Liu YK.
Xu DQ.
Xu ZY.
Zhang YM.
J. Zhejiang Univ., SCIENCE B
2006,
7:
393
- 21
Tanaka H.
Kuroboshi M.
Curr. Org. Chem.
2004,
8:
1027
-
According to literature reports, in the 1H NMR spectrum of a trisubstituted alkene the β-vinylic protons, cis and trans to the ester group, are known to resonate at around δ = 7.5 and 6.5 ppm, respectively, when the alkene is substituted by an aryl group; while the same proton cis and trans to an ester group appears at around δ = 6.8 and 5.7 ppm, respectively, when substituted by an alkyl group. See:
-
22a
Larson GL.
de Kaifer CF.
Seda R.
Torres LE.
Ramirez JR.
J. Org. Chem.
1984,
49:
3385
-
22b
Basavaiah D.
Sarma PKS.
Bhavani AKD.
J. Chem. Soc., Chem. Commun.
1994,
1091
-
22c
Baraldi PG.
Guarneri M.
Pollini GP.
Simoni D.
Barco A.
Benetti S.
J. Chem. Soc., Perkin Trans. 1
1984,
2501
-
22d
Tanaka K.
Yamagishi N.
Tanikaga R.
Kaji A.
Bull. Chem. Soc. Jpn.
1983,
56:
528
-
23a
Tanaka H.
Yamashita S.
Yamanoue M.
Torri S.
J. Org. Chem.
1989,
54:
444
-
23b
Tanaka H.
Yamashita S.
Katayama Y.
Torri S.
Chem. Lett.
1986,
2043
-
23c
Tanaka H.
Yamashita S.
Ikemoto Y.
Torri S.
Chem. Lett.
1987,
673
-
23d
Tanaka H.
Yamashita S.
Ikemoto Y.
Torri S.
Tetrahedron Lett.
1988,
29:
1721
-
24a
Falck JR.
He A.
Bejot R.
Mioskowski C.
Synlett
2006,
2652
-
24b
Baati R.
Barma DK.
Krishna UM.
Mioskowski C.
Falck JR.
Tetrahedron Lett.
2002,
43:
959
25
General Procedure for the Synthesis of 2-(2,2,2-Tri-chloroethyl)alk-2-enoates 2
In a 25 mL flask were added Al powder (0.032 g, 1.2 mmol), PbCl2 (0.055g, 0.2 mmol), Baylis-Hillman acetate 1 (1 mmol), CCl4 (0.20 mL, 2.0 mmol), and anhyd DMF (5 mL). The mixture was stirred at r.t. for 2-4 h. Upon completion, the solvent was removed under vacuum. Then, to the flask was added 10 mL 5% HCl for quenching the reaction, and the mixture was extracted by CH2Cl2 (2 × 30 mL), washed with brine (15 mL), dried over MgSO4. After evaporation of the solvent, the residue was purified by chromatography using cyclohexane-EtOAc (6:1) as eluent to give pure 2.
26
Data for Compounds 2
Compound (E)-2a: 1H NMR (400 MHz, CDCl3): δ = 3.85 (s, 3 H, OCH3), 4.17 (s, 2 H, CH2), 7.32-7.39 (m, 5 H, ArH), 7.94 (s, 1 H, ArCH=). 13C NMR (100 MHz, CDCl3): δ = 49.56, 52.32, 98.27, 126.66, 128.69, 128.84, 128.92, 134.88, 144.85, 168.27. IR (film): ν = 3060, 3028, 2952, 1724, 1633, 1577 cm-1. MS (70 eV): m/z (%) = 292 [M+]. Anal. Calcd for C12H11Cl3O2: C, 49.09; H, 3.78. Found: C, 49.38; H, 3.74.
Compound (E)-2b: 1H NMR (400 MHz, CDCl3): δ = 2.37 (s, 3 H, CH3), 3.86 (s, 3 H, OCH3), 4.19 (s, 2 H, CH2), 7.21 (d, 2 H, J = 8.0 Hz, ArH), 7.35 (d, 2 H, J = 8.0 Hz, ArH), 7.91 (s, 1 H, ArCH=). 13C NMR (100 MHz, CDCl3): δ = 21.30, 49.74, 52.31, 98.48, 125.76, 129.14, 129.46, 131.97, 139.33, 144.98, 168.54. IR (film): ν = 3027, 3025, 2997, 2952, 1720, 1632, 1609 cm-1. MS (70 eV): m/z (%) = 306 [M+]. Anal. Calcd for C13H13Cl3O2: C, 50.76; H, 4.26. Found: C, 50.48; H, 4.30.
Compound (E)-2c: 1H NMR (400 MHz, CDCl3): δ = 3.84 (s, 3 H, OCH3), 3.86 (s, 3 H, OCH3), 4.10 (s, 2 H, CH2), 6.91 (d, 1 H, J = 8.0 Hz, ArH), 6.98 (t, 1 H, J = 8.0 Hz, ArH), 7.29 (d, 1 H, J = 8.0 Hz, ArH), 7.34 (t, 1 H, J = 8.0 Hz, ArH), 8.03 (s, 1 H, ArCH=). 13C NMR (100 MHz, CDCl3): δ = 50.0, 52.28, 55.53, 98.51, 111.0, 120.54, 124.35, 126.91, 129.10, 130.36, 141.97, 157.29, 168.27. IR (film): ν = 3042, 3001, 2951, 2846, 1719, 1637, 1597 cm-1. MS (70 eV): m/z (%) = 322 [M+]. Anal. Calcd for C13H13Cl3O3: C, 48.25; H, 4.05. Found: C, 48.53; H, 4.08.
Compound (E)-2d: 1H NMR (400 MHz, CDCl3): δ = 3.84 (s, 3 H, OCH3), 4.17 (s, 2 H, CH2), 6.0 (s, 2 H, OCH2O), 6.83 (d, 1 H, J = 8.0 Hz, ArH), 6.95 (d, 1 H, J = 8.0 Hz, ArH), 6.99 (s, 1 H, ArH), 7.83 (s, 1 H, ArCH=). 13C NMR (100 MHz, CDCl3): δ = 49.56, 52.30, 98.41, 101.44, 108.55, 108.84, 124.39, 124.90, 128.57, 144.52, 147.96, 148.39, 168.48. IR (film): ν = 3054, 3002, 2900, 1718, 1616 cm-1. MS (70 eV): m/z (%) = 336 [M+]. Anal. Calcd for C13H11Cl3O4: C, 46.25; H, 3.28. Found: C, 46.52; H, 3.25
Compound (E)-2e: 1H NMR (400 MHz, CDCl3): δ = 3.86 (s, 3 H, OCH3), 4.13 (s, 2 H, CH2), 7.35 (d, 2 H, J = 8.0 Hz, ArH), 7.40 (d, 2 H, J = 8.0 Hz, ArH), 7.88 (s, 1 H, ArCH=). 13C NMR (100 MHz, CDCl3): δ = 49.59, 52.48, 98.10, 127.33, 129.07, 130.22, 133.37, 142.13, 143.51, 168.10. IR (film): ν = 3003, 2952, 2850, 1710, 1635, 1591 cm-1. MS (70 eV): m/z (%) = 328 [M+]. Anal. Calcd for C12H10Cl4O2: C, 43.94; H, 3.07. Found: C, 43.68; H, 3.11.
Compound (E)-2f: 1H NMR (400 MHz, CDCl3): δ = 3.88 (s, 3 H, OCH3), 4.04 (s, 2 H, CH2), 7.21-7.43 (m, 4 H, ArH), 7.97 (s, 1 H, ArCH=). 13C NMR (100 MHz, CDCl3): δ = 49.41, 52.50, 97.70, 126.18, 128.43, 129.25, 129.79, 129.90, 133.87, 142.41, 167.60. IR (film): ν = 3061, 2998, 2952, 1721, 1641, 1590 cm-1. MS (70 eV): m/z (%) = 328 [M+]. Anal. Calcd for C12H10Cl4O2: C, 43.94; H, 3.07. Found: C, 43.75; H, 3.04.
Compound (E)-2g: 1H NMR (400 MHz, CDCl3): δ = 3.88 (s, 3 H, OCH3), 4.01 (s, 2 H, CH2), 7.24 (d, 1 H, J = 8.0 Hz, ArH), 7.29 (d, 1 H, J = 8.0 Hz, ArH), 7.45 (s, 1 H, ArH), 7.89 (s, 1 H, ArCH=). 13C NMR (100 MHz, CDCl3): δ = 49.34, 52.54, 97.49, 127.25, 128.98, 129.70, 130.0, 132.37, 134.59, 135.12, 140.07, 141.12, 166.50. IR (film): ν = 3092, 3001, 2954, 1729, 1643, 1586 cm-1. MS (70 eV): m/z (%) = 362 [M+]. Anal. Calcd for C12H9Cl5O2: C, 39.76; H, 2.50. Found: C, 39.51; H, 2.53.
Compound (E)-2h: 1H NMR (400 MHz, CDCl3): δ = 3.90 (s, 3 H, OCH3), 4.13 (s, 2 H, CH2), 7.64 (t, 1 H, J = 8.0 Hz, ArH), 7.75 (d, 1 H, J = 8.0 Hz, ArH), 7.97 (s, 1 H), 8.22 (d, 1 H, J = 8.0 Hz, ArH), 8.27 (s, 1 H). 13C NMR (100 MHz, CDCl3): δ = 49.26, 52.61, 97.62, 123.37, 129.15, 129.84, 134.41, 136.54, 140.81, 141.90, 148.22, 167.45. IR (film): ν = 3086, 2954, 1725, 1639, 1532 cm-1. MS (70 eV):
m/z (%) = 337 [M+]. Anal. Calcd for C12H10Cl3NO2: C, 42.57; H, 2.98. Found: C, 42.33; H, 2.95.
Compound (E)-2i: 1H NMR (400 MHz, CDCl3): δ = 3.83 (s, 3 H, OCH3), 4.39 (s, 2 H, CH2), 6.51 (d, 1 H, J = 1.2 Hz, ArH), 6.74 (dd, 1 H, J
1 = 4.0 Hz, J
2 = 1.2 Hz, ArH), 7.42 (s, 1 H, ArCH=), 7.59 (d, 1 H, J = 4.0 Hz, ArH). 13C NMR (100 MHz, CDCl3): δ = 50.44, 52.30, 98.64, 112.16, 118.54, 121.02, 130.39, 145.17, 150.41, 168.35. IR (film): ν = 2952, 1717, 1636 cm-1. MS (70 eV): m/z (%) = 282 [M+]. Anal. Calcd for C10H9Cl3O3: C, 42.36; H, 3.20. Found: C, 42.58; H, 3.25.
Compound (E)-2j: 1H NMR (400 MHz, CDCl3): δ = 2.68 (q, 2 H, J = 8.0 Hz, CH2), 2.78 (t, 2 H, J = 8.0 Hz, CH2), 3.77 (s, 3 H, OCH3), 3.78 (s, 2 H, CH2), 7.09 (t, 1 H, J = 8.0 Hz, CH=), 7.16-7.31 (m, 5 H, ArH). 13C NMR (100 MHz, CDCl3): δ = 31.88, 34.44, 50.07, 52.11, 98.68, 126.27, 128.24, 128.36, 128.51, 140.42, 148.00, 167.73. IR (film): ν = 3063, 3028, 2950, 1723, 1646, 1603 cm-1. MS (70 eV): m/z (%) = 320 [M+]. Anal. Calcd for C14H15Cl3O2: C, 52.28; H, 4.70. Found: C, 52.54; H, 4.64.
Compound (E)-2k: 1H NMR (400 MHz, CDCl3): δ = 0.88 (t, 3 H, J = 6.8 Hz, CH3), 1.27-1.33 (m, 10 H), 2.37 (q, 2 H, J = 8.0 Hz, CH2), 3.78 (s, 3 H, OCH3), 3.85 (s, 2 H, CH2), 7.06 (t, 1 H, J = 8.0 Hz, CH=). 13C NMR (100 MHz, CDCl3): δ = 13.99, 22.55, 28.41, 29.01, 29.29, 30.08, 31.65, 50.20, 52.02, 98.88, 125.71, 149.75, 167.92. IR (film): ν = 2927, 2856, 1724, 1646 cm-1. MS (70 eV): m/z (%) = 314 [M+]. Anal. Calcd for C13H21Cl3O2: C, 49.46; H, 6.71. Found: C, 49.28; H, 6.66.